SYBLEU INC.
SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and … Read more
Market Cap & Net Worth: SYBLEU INC. (SYBE)
SYBLEU INC. (PINK:SYBE) has a market capitalization of $583.74K ($583.74K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #39848 globally and #12961 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SYBLEU INC.'s stock price $0.06 by its total outstanding shares 10613492 (10.61 Million).
SYBLEU INC. Market Cap History: 2023 to 2025
SYBLEU INC.'s market capitalization history from 2023 to 2025. Data shows change from $402.25K to $583.74K (-31.26% CAGR).
SYBLEU INC. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SYBLEU INC.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SYBE by Market Capitalization
Companies near SYBLEU INC. in the global market cap rankings as of March 19, 2026.
Key companies related to SYBLEU INC. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
SYBLEU INC. Historical Marketcap From 2023 to 2025
Between 2023 and today, SYBLEU INC.'s market cap moved from $402.25K to $ 583.74K, with a yearly change of -31.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $583.74K | 0.00% |
| 2024 | $583.74K | +45.12% |
| 2023 | $402.25K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SYBLEU INC. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $583.74K USD |
| MoneyControl | $583.74K USD |
| MarketWatch | $583.74K USD |
| marketcap.company | $583.74K USD |
| Reuters | $583.74K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.